On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a decision affecting nearly $500 million in federal investments. The announcement ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Effectiveness didn't ...

Simultaneous administration of a COVID-19 mRNA booster shot and the seasonal influenza vaccine slightly increased the risk of systemic reactions during the following week compared with a booster shot ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Adults in England aged 50 years or older who received the bivalent BA.1 mRNA booster vaccine during the 2022 autumn campaign had substantially lower risks for COVID-related hospitalisation and death ...

A new Centers for Disease Control and Prevention study says booster shots of Pfizer's and Moderna's COVID-19 vaccines proved vital in keeping additional Americans out of the hospital as the omicron ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

Scientists have found that the risk of shingles may rise slightly in the weeks following a Covid booster shot. The discovery comes from researchers at the University of Groningen in the Netherlands, ...

Add Yahoo as a preferred source to see more of our stories on Google. RFK Jr. canceled $500 million of funding for research on mRNA vaccine technology. Anadolu/Getty Images At a Sept. 4, 2025, hearing ...

JN.1-targeted mRNA boosters developed for the 2024-2025 COVID-19 season were effective and safe in Danish seniors, according to two register-based cohort studies that suggested Europe may have ...